Status:
COMPLETED
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Kubota Vision Inc.
Collaborating Sponsors:
Otsuka Pharmaceutical Co., Ltd.
Conditions:
Primary Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
This is a study of the safety, tolerability, pharmacokinetics (measurement of drug levels in the blood), and intraocular pressure lowering effects of OPA-6566 ophthalmic solution in subjects with prim...
Eligibility Criteria
Inclusion
- diagnosis of bilateral primary open-angle glaucoma
- diagnosis of ocular hypertension as defined in the protocol
Exclusion
- any form of glaucoma other than primary open-angle glaucoma in either eye
- other ocular conditions as defined by the protocol
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01410188
Start Date
September 1 2011
End Date
October 1 2012
Last Update
March 11 2014
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Artesia, California, United States, 90701
2
Glendale, California, United States, 91205
3
Roswell, Georgia, United States, 30076
4
Louisville, Kentucky, United States, 40217